BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29400695)

  • 1. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis.
    Zhou B; Flodby P; Luo J; Castillo DR; Liu Y; Yu FX; McConnell A; Varghese B; Li G; Chimge NO; Sunohara M; Koss MN; Elatre W; Conti P; Liebler JM; Yang C; Marconett CN; Laird-Offringa IA; Minoo P; Guan K; Stripp BR; Crandall ED; Borok Z
    J Clin Invest; 2018 Mar; 128(3):970-984. PubMed ID: 29400695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-18: unexpected regulator of lung alveolar epithelial cell proliferation.
    Kotton DN
    J Clin Invest; 2018 Mar; 128(3):903-905. PubMed ID: 29400691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
    Luo J; Chimge NO; Zhou B; Flodby P; Castaldi A; Firth AL; Liu Y; Wang H; Yang C; Marconett CN; Crandall ED; Offringa IA; Frenkel B; Borok Z
    Int J Cancer; 2018 Dec; 143(12):3169-3180. PubMed ID: 30325015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichotomous roles of claudins as tumor promoters or suppressors: lessons from knockout mice.
    Kage H; Flodby P; Zhou B; Borok Z
    Cell Mol Life Sci; 2019 Dec; 76(23):4663-4672. PubMed ID: 31332482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-18 deficiency results in alveolar barrier dysfunction and impaired alveologenesis in mice.
    LaFemina MJ; Sutherland KM; Bentley T; Gonzales LW; Allen L; Chapin CJ; Rokkam D; Sweerus KA; Dobbs LG; Ballard PL; Frank JA
    Am J Respir Cell Mol Biol; 2014 Oct; 51(4):550-8. PubMed ID: 24787463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
    Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
    Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling.
    Xu X; Li Y; Zhang R; Chen X; Shen J; Yuan M; Chen Y; Chen M; Liu S; Wu J; Sun Q
    J Ethnopharmacol; 2023 Jul; 311():116450. PubMed ID: 37023839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Tight Junction Protein Claudin 18 Promotes Progressive Neoplasia Development in Mouse Stomach.
    Hagen SJ; Ang LH; Zheng Y; Karahan SN; Wu J; Wang YE; Caron TJ; Gad AP; Muthupalani S; Fox JG
    Gastroenterology; 2018 Dec; 155(6):1852-1867. PubMed ID: 30195448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
    Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
    Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual function of Yap in the regulation of lens progenitor cells and cellular polarity.
    Song JY; Park R; Kim JY; Hughes L; Lu L; Kim S; Johnson RL; Cho SH
    Dev Biol; 2014 Feb; 386(2):281-90. PubMed ID: 24384391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.
    Ye XY; Luo QQ; Xu YH; Tang NW; Niu XM; Li ZM; Shen SP; Lu S; Chen ZW
    J Cell Mol Med; 2015 Mar; 19(3):651-63. PubMed ID: 25712415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
    Han Y; Tang Z; Zhao Y; Li Q; Wang E
    Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yap and its subcellular localization have distinct compartment-specific roles in the developing lung.
    van Soldt BJ; Qian J; Li J; Tang N; Lu J; Cardoso WV
    Development; 2019 May; 146(9):. PubMed ID: 30944105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors.
    Mahoney JE; Mori M; Szymaniak AD; Varelas X; Cardoso WV
    Dev Cell; 2014 Jul; 30(2):137-50. PubMed ID: 25043473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.
    Szymaniak AD; Mi R; McCarthy SE; Gower AC; Reynolds TL; Mingueneau M; Kukuruzinska M; Varelas X
    Elife; 2017 May; 6():. PubMed ID: 28492365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
    Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
    Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
    Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
    Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.